Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT02557321 |
| Title | PV-10 in Combination With Pembrolizumab for Treatment of Metastatic Melanoma |
| Recruitment | Active, not recruiting |
| Gender | both |
| Phase | Phase Ib/II |
| Variant Requirements | No |
| Sponsors | Provectus Pharmaceuticals |
| Indications | |
| Therapies | |
| Age Groups: | adult |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Moffitt Cancer Center | Tampa | Florida | 33612 | United States | Details | |
| Dartmouth-Hitchcock Medical Center | Lebanon | New Hampshire | 03756 | United States | Details | |
| Oregon Health & Science University | Portland | Oregon | 97239 | United States | Details | |
| St Luke's University Health Network | Easton | Pennsylvania | 18045 | United States | Details | |
| MD Anderson Cancer Center | Houston | Texas | 77230 | United States | Details |